Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

American Vanguard Buys QPE Herbicides Products From Corteva

Published 01/04/2019, 06:07 AM
Updated 07/09/2023, 06:31 AM

American Vanguard Corporation (NYSE:AVD) announced the acquisition of Quizalofop (QPE) herbicides product line from Corteva Agriscience, the Agriculture Division of DowDuPont (NYSE:DWDP) . These products have primary markets in Pulse, Canola and Soybeans across Canada and the United States.

The deal includes purchase of commercial sales information, technical registrations and transfer of existing product supply arrangements. However, financial terms of the transaction have been kept under wraps.

The buyout provides American Vanguard’s crop protection business with a portfolio of herbicide brands holding significant leadership positions in the North American market. These are complementary to the existing glufosinate, glyphosate and 2,4D usage and is highly known for grass and weed control by providing outstanding crop safety and application.

Moreover, DowDuPont Enlist seed trait technology for corn offers crop tolerance to QPE herbicides, which facilitates better weed management. The takeover has granted American Vanguard a license to market QPE for use alone or with Enlist herbicides over-the-top of the new Enlist corn seeds.

These herbicide products have a firm market position with strong profitability. The product suite also aids growth as the Enlist trait technology expands. Following this deal, the company acquired the rights to market in Chile and Argentina, which in turn, strengthens its market access in the South American region.

Shares of American Vanguard have lost 32% over the past six months, underperforming the 12.1% decline of the industry it belongs to.



During third-quarter 2018 earnings call, the company stated that it sees strong sales from its soil fumigants and Equus fungicide as well as from its domestic non-crop and Central America distribution businesses on a year-over-year basis in the fourth quarter.

The company also envisions sustained demand for its products in fruits and vegetables as well as pre-season purchasing demand for its corn products going into the 2019 spring planting season.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

American Vanguard Corporation Price and Consensus

Zacks Rank & Stocks to Consider

American Vanguard currently carries a Zacks Rank #3 (Hold). A few better-ranked stocks in the basic materials space are Verso Corp. (NYSE:VRS) and Ingevity Corp. (NYSE:NGVT) .

Verso has an expected earnings growth rate of 63.5% for 2019 and a Zacks Rank #1 (Strong Buy). The stock has surged 33.7% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.

Ingevity has an expected earnings growth rate of 21.5% for 2019 and a Zacks Rank #2 (Buy). Shares of the company have rallied 8% in a year.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



American Vanguard Corporation (AVD): Free Stock Analysis Report

Ingevity Corporation (NGVT): Free Stock Analysis Report

Verso Corporation (VRS): Free Stock Analysis Report

Dow Chemical Company (NYSE:DOW

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.